Argatroban — 250MG, Injection, 1 × 2.5 mL vial

Argatroban — 250MG, Injection, 1 × 2.5 mL vial

Argatroban is a injection for intravenous use. Argatroban is a direct thrombin inhibitor indicated: For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) ( 1.1 ) As an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI) ( 1.2 ) 1.1 Heparin-Induced Thrombocytopenia Argatroban Injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT). 1.2 Percutaneous Coronary Intervention Argatroban Injection is indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).

• Active ingredient or product type: ARGATROBAN
• Strength/concentration: 250MG
• Dosage form and route: Injection, Intravenous
• Exact package presentation: 1 × 2.5 mL vial
• NDC/item number: 0143-9674-01
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store the vials in original carton at 20° to 25° C (68° to 77° F) [See USP Controlled Room Temperature]. Do not freeze. protect from light.
• Status: Rx only

Important safety information: Hemorrhage can occur.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.